The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Bruno Paiva | ASH 2018 | The clinical significance of MRD for high-risk multiple myeloma 

Dec 4, 2018

60th ASH Annual Meeting & Exposition, December 1–4 2018, San Diego, CA

Bruno Paiva
University of Navarra, Pamplona, ES

Bruno Paiva | ASH 2018 | The clinical significance of MRD for high-risk multiple myeloma